Biolytical Commodities-SP w/SS Conditions

The State of Illinois, through the Illinois Department of Public Health, is conducting a small purchase with sole source conditions procurement for Insti Rapid Antibody qualitative tests for the detection of antibodies to Human Immunodeficiency Virus Type 1 & Type 2. The state is seeking to procure 4,000 Insti HIV/HIV-2 Antibody Tests and 80 Insti HIV/HIV-2 Controls, with delivery to the Illinois Department of Public Health in Springfield, Illinois. The winning vendor must possess all mandatory qualifications and offer the lowest bid, with the Insti HIV/HIV-2 Antibody Tests quoted at $12.99 each and the Insti HIV/HIV-2 Controls quoted at $76.99 each, for a total quoted amount of $58,119.20. Quotes must be submitted by the bid opening date of May 30, 2023, and the quote must be valid for 90 days from the date of submission. The agency reserves the right to reject all offers or individual offers for failure to meet any requirement.

The procurement opportunity is open to all qualified vendors, and there are no set-aside designations or restrictions on the types of organizations that can respond. The Standard Terms and Conditions document and the Standard Illinois Certifications apply to this procurement, covering a variety of contractual requirements, procedures, and compliance standards. The contract will be for a one-time purchase, and details on any incumbent vendors or current contractors, as well as possible award values or budget ranges, are not provided in the available documents.